Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Expert Opinion on Therapeutic Patents(1)
Frontiers in Pharmacology(1)
Frontiers in Physiology(1)
Toxicon(1)
Vaccines(1)
A Comparative Analysis of a Self-Reported Adverse Events Analysis after Receiving One of the Available SARS-CoV-2 Vaccine Schemes in Ecuador
ArticleAbstract: The COVID-19 pandemic has put a lot of pressure on health systems worldwide. Mass vaccination againsPalabras claves:Adverse events, covid-19, pandemic, SARS-COV-2, self-reporting, vaccinesAutores:Barbara Coronel, Cordovez S.P., Esteban Ortiz-Prado, Jorge Vásconez-González, Juan S. Izquierdo-Condoy, Karen Delgado-Moreira, Katherine Simbaña-Rivera, Lincango-Naranjo E.P., Raúl Patricio Fernández-Naranjo, Ruth Jimbo-SotomayorFuentes:scopusDrug prices and trends before and after requesting compulsory licenses: the Ecuadorian experience
ReviewAbstract: Introduction: The Ecuadorian Institute of Intellectual Property (IEPI) granted several compulsory liPalabras claves:Compulsory licenses, ECUADOR, Enfarma, generic drugs, patentAutores:Daniel Borrero-Maldonado, Enrique Terán, Esteban Ortiz-Prado, Gabriel H. Cevallos-Sierra, Jorge Eduardo Vásconez, Katherine Simbaña-Rivera, Lenin Gómez-Barreno, Ponce-Zea J.Fuentes:scopusHematological Parameters, Lipid Profile, and Cardiovascular Risk Analysis Among Genotype-Controlled Indigenous Kiwcha Men and Women Living at Low and High Altitudes
ArticleAbstract: Introduction: Human adaptation to high altitude is due to characteristic adjustments at every physioPalabras claves:Adaptation, Cardiovascular Risk, hematological profile, High altitude, Hypoxia, lipid profileAutores:David Portilla, Duta D., Esteban Ortiz-Prado, Germán Burgos, Johanna Mosquera-Moscoso, Jorge Eduardo Vásconez, Juan S. Izquierdo-Condoy, Katherine Simbaña-Rivera, Manuel H. Calvopina, Ochoa I., Viscor G.Fuentes:googlescopusPulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials
ArticleAbstract: Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-19. RespPalabras claves:clinical trials, drugs, lethal COVID-19, pulmonary inflammatory response, single nucleus RNA sequencingAutores:Alejandro Cabrera-Andrade, Álvaro A. Pérez-Meza, Ana María Gómez-Jaramillo, Andrea Abad-Sojos, Andrea V. Jácome, Andrés López-Cortés, Andy Pérez-Villa, Ángela León-Cáceres, Antonella Vera-Guapi, Ariana León-Sosa, Cevallos-Robalino D., Echeverría-Garcés G., Esteban Ortiz-Prado, Estefanía Abarca, Fernanda Arias-Erazo, Isaac Armendáriz-Castillo, Jennyfer M. García-Cárdenas, Jhommara Bautista, Katherine Simbaña-Rivera, Lourdes Puig San Andrés, Luis Fuenmayor-González, Morillo A., Nieto-Jaramillo K., Nikolaos C. Kyriakidis, P. Guevara-Ramírez, Quiñones L.A., Ramos-Medina M.J., Santiago Xavier Guerrero, Verónica YumicebaFuentes:scopusSnake antivenom production in Ecuador: Poor implementation, and an unplanned cessation leads to a call for a renaissance
ReviewAbstract: Snakebite envenomation is a global health problem. This health problem asymmetrically affects ruralPalabras claves:antivenom, ECUADOR, epidemiology, PUBLIC HEALTH, Serum, Snake antivenom, snakebiteAutores:Camila Schiavi-Guzman, Enrique Terán, Esteban Ortiz-Prado, Felipe Andrade, Juan S. Izquierdo-Condoy, Justin Yeager, Katherine Simbaña-Rivera, Lenin Gómez-Barreno, Paola Abedrabbo-FigueroaFuentes:scopus